Thymic carcinoma

From Libre Pathology
Jump to: navigation, search

Thymic carcinoma is a malignant tumour of the thymus. It was previously known as thymic tumour type C.

General

  • Rare.
  • Usually arise de novo, i.e. thymoma is not generally a precursor.
  • Risk factors - possibly: smoking, radiation.[1]

Microscopic

Features:[2]

Notes:

  • Staging depends on capsular invasion.

DDx:

Images

IHC

Features:[2]

  • CD5 +ve (90% of cases[1]).[5]
  • CD117 +ve (87% of cases[1]).
  • CD7 +ve.
  • TTF-1 -ve.

Note:

See also

References

  1. 1.0 1.1 1.2 1.3 Thomas de Montpréville, V.; Ghigna, MR.; Lacroix, L.; Besse, B.; Broet, P.; Dartevelle, P.; Fadel, E.; Dorfmuller, P. (Mar 2013). "Thymic carcinomas: clinicopathologic study of 37 cases from a single institution.". Virchows Arch 462 (3): 307-13. doi:10.1007/s00428-013-1371-y. PMID 23319214.
  2. 2.0 2.1 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 147. ISBN 978-0781765275.
  3. Zhao, Y.; Zhao, H.; Hu, D.; Fan, L.; Shi, J.; Fang, W. (Sep 2013). "Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.". Ann Thorac Surg 96 (3): 1019-24. doi:10.1016/j.athoracsur.2013.04.078. PMID 23866799.
  4. Rossi, V.; Donini, M.; Sergio, P.; Passalacqua, R.; Rossi, G.; Buti, S. (Apr 2013). "When a thymic carcinoma becomes a GIST.". Lung Cancer 80 (1): 106-8. doi:10.1016/j.lungcan.2013.01.003. PMID 23375402.
  5. Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 708. ISBN 0-7216-0187-1.